• Subscribe
  • Newsfeed
  • About
  • Jobs
AI Search
Announce News

Lucid Capital: Investment Portfolio & Startup News

Lucid Capital

To add a bio or update investment portfolio click update information.

Investment Portfolio

    Conduct unlocks £45m Series A led by Index Ventures and ICONIQ to accelerate transformation of enterprise software systemsConduct unlocks £45m Series A led by Index Ventures and ICONIQ to accelerate transformation of enterprise software systems
    Conduct
    19 Jun 2026

    Conduct unlocks £45m Series A led by Index Ventures and ICONIQ to accelerate transformation of enterprise software systems

    Conduct is an AI operating system for enterprise software that ingests custom code, configuration, and dependencies to build a single operating layer linking each step of a business process to the code that implements it. The platform enables business and IT teams to work together to transform complex, highly customised enterprise systems faster and at lower cost.

    Conduct emerges from stealth with £9m seed led by Creandum to transform ERP operations with AI agentsConduct emerges from stealth with £9m seed led by Creandum to transform ERP operations with AI agents
    Conduct
    18 Sept 2025

    Conduct emerges from stealth with £9m seed led by Creandum to transform ERP operations with AI agents

    Conduct builds AI agents that help large organisations understand and modernise complex ERP systems, giving teams visibility into business logic, incidents and migration risks.

Lucid Capital
    • Enterprise
  • 1(12 months)
  • lucidcap.co

More venture news

  • Boltz announces its £85m Series A round led by Bessemer Venture Partners to build AI models for molecular design
    Boltz
    18 Nov 2026

    Boltz announces its £85m Series A round led by Bessemer Venture Partners to build AI models for molecular design

    Series ALife Sciences
  • Zya lands a £12m Series A round led by Astanor to turn sugar in food into prebiotic fibre
    Zya
    16 Nov 2026

    Zya lands a £12m Series A round led by Astanor to turn sugar in food into prebiotic fibre

    Series AHealth
  • Oyster Therapeutics secures a £45m Series A round from CE-Ventures to develop an oral drug for neurodegenerative diseases
    Oyster Therapeutics
    13 Nov 2026

    Oyster Therapeutics secures a £45m Series A round from CE-Ventures to develop an oral drug for neurodegenerative diseases

    Series ALife Sciences

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn